av/reviva-pharmaceuticals--big.svg

NASDAQ:RVPHW

Reviva Pharmaceuticals

  • Stock

0.87

−1.96%

0.41

USD last updated 13/08 01:59:42

Last Close

0.46

12/08 22:26

Market Cap

34.89M

Beta: -

Volume Today

316.77K

Avg: -

PE Ratio

−2.39

PFCF: −4.77

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.5-0.4-0.3-0.2-0.12022-12-312022-12-302023-03-312023-03-302023-06-302023-06-29

    Revenue (Estimate*)

    0.000.000.010.010.012022-12-312022-12-302023-03-312023-03-302023-06-302023-06-29

    *Estimate based on analyst consensus